Early Surgery Tied to Increased Mortality in Polytraumatized

This article originally appeared here.
Share this content:
Early Surgery Tied to Increased Mortality in Polytraumatized
Early Surgery Tied to Increased Mortality in Polytraumatized

WEDNESDAY, July 29, 2015 (HealthDay News) -- For polytraumatized patients, surgery for thoracic spine trauma within 72 hours of trauma is associated with increased mortality, according to a study published in the Aug. 1 issue of The Spine Journal.

Markus R. Konieczny, M.D., from the University Hospital Bergmannsheil in Bochum, Germany, and colleagues conducted a prospective study to validate retrospective data on the effect of timing of surgery on outcomes of polytraumatized patients with severe lesions of the thoracic spine. Thirty-eight multiple-injured patients with unstable fractures of vertebral column from level Th1 to L1 were enrolled. Twenty-two patients underwent early surgery (≤72 hours post trauma), while 16 received late surgery (≥72 hours post trauma).

The researchers found that the mortality rate was significantly higher for patients who received early versus late surgery. Mortality was 67 percent among patients with an initial hemoglobin (Hb) of less than 10 mg/dL and 75 percent for those who had an Hb less than 10 mg/dL and received a thoracic drain.

"Although some reports indicate advantages for early surgery for thoracic spine trauma in the polytraumatized patient, careful patient selection should be used," the authors write. "Based on the results of this prospective study, early surgery for thoracic spine trauma in patients with concomitant severe thoracic trauma and low initial Hb levels may pose a risk for poor clinical outcomes."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Panel Has Tie Vote on New Type 1 Diabetes Drug

FDA Panel Has Tie Vote on New Type ...

Zynquista is a once-daily pill meant to help type 1 diabetes patients manage their blood glucose levels

FDA Investigating Paclitaxel-Coated Balloons, Paclitaxel-Eluting Stents

FDA Investigating Paclitaxel-Coated Balloons, Paclitaxel-Eluting Stents

Investigation triggered by meta-analysis showing possible increased mortality in PAD patients at 2 years

Frailty Could Increase Susceptibility for Dementia

Frailty Could Increase Susceptibility for Dementia

Authors say frailty should be considered in clinical care, management of Alzheimer dementia

is free, fast, and customized just for you!




Already a member?

Sign In Now »